Most cited
- Page Path
-
- HOME
- BROWSE ARTICLES
- Most cited
- Original Article
- Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
- Clin Mol Hepatol. 2023;29(3):721-732. Published online March 22, 2023
-
View: 18430 Download: 1,535 Web of Science: 184 Crossref: 202
- Review
- Global incidence and prevalence of nonalcoholic fatty liver disease
- Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
- Clin Mol Hepatol. 2023;29(Suppl):S32-S42. Published online December 14, 2022
-
View: 11917 Download: 479 Web of Science: 114 Crossref: 140
- Guideline
- 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
- Clin Mol Hepatol. 2022;28(4):583-705. Published online October 1, 2022
-
View: 14068 Download: 743 Web of Science: 116 Crossref: 119
- Review
- MAFLD: How is it different from NAFLD?
- Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
- Clin Mol Hepatol. 2023;29(Suppl):S17-S31. Published online November 29, 2022
-
View: 15367 Download: 1,170 Web of Science: 84 Crossref: 103
- Original Article
- Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
- Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
- Clin Mol Hepatol. 2022;28(4):841-850. Published online September 19, 2022
-
View: 7819 Download: 254 Web of Science: 88 Crossref: 93
- Review
- MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
- Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
- Clin Mol Hepatol. 2022;28(2):150-163. Published online November 10, 2021
-
View: 8053 Download: 381 Web of Science: 60 Crossref: 59
- Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
- Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin
- Clin Mol Hepatol. 2023;29(1):77-98. Published online October 13, 2022
-
View: 10503 Download: 684 Web of Science: 46 Crossref: 55
- Original Article
- Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
- Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, Jieling Xiao, Phoebe Tay, Margaret Teng, Keng Siang Lee, Snow Yunni Lin, May Zin Myint, Benjamin Tan, Vijay K Sharma, Darren Jun Hao Tan, Wen Hui Lim, Apichat Kaewdech, Daniel Huang, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark Muthiah, Cheng Han Ng
- Clin Mol Hepatol. 2022;28(3):483-496. Published online March 2, 2022
-
View: 7891 Download: 276 Web of Science: 45 Crossref: 54
- Guideline
- KASL clinical practice guidelines for management of chronic hepatitis B
- Clin Mol Hepatol. 2022;28(2):276-331. Published online April 1, 2022
-
DOI: https://doi.org/10.3350/cmh.2022.0084 Correction in: Clin Mol Hepatol 2022;28(4):940
-
View: 11409 Download: 609 Web of Science: 44 Crossref: 52
- Original Article
- The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
- Cheng Han Ng, Kai En Chan, Yip Han Chin, Rebecca Wenling Zeng, Pei Chen Tsai, Wen Hui Lim, Darren Jun Hao Tan, Chin Meng Khoo, Lay Hoon Goh, Zheng Jye Ling, Anand Kulkarni, Lung-Yi Loey Mak, Daniel Q Huang, Mark Chan, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mark Muthiah
- Clin Mol Hepatol. 2022;28(3):565-574. Published online May 19, 2022
-
View: 7341 Download: 204 Web of Science: 47 Crossref: 50
- Review
- Non-alcoholic fatty liver disease: Definition and subtypes
- Seul Ki Han, Soon Koo Baik, Moon Young Kim
- Clin Mol Hepatol. 2023;29(suppl):S5-S16. Published online December 28, 2022
-
View: 7621 Download: 518 Web of Science: 45 Crossref: 50
- Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
- Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
- Clin Mol Hepatol. 2022;28(4):790-801. Published online May 11, 2022
-
View: 7581 Download: 505 Web of Science: 44 Crossref: 44
- RNA interference as a novel treatment strategy for chronic hepatitis B infection
- Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2022;28(3):408-424. Published online February 17, 2022
-
View: 8979 Download: 639 Web of Science: 38 Crossref: 43
- The management of post-transplantation recurrence of hepatocellular carcinoma
- Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin
- Clin Mol Hepatol. 2022;28(1):1-16. Published online October 5, 2021
-
View: 8723 Download: 350 Web of Science: 32 Crossref: 35
- Original Article
- COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
- Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, Ruiqi Zhang, Ivan FN Hung, Wai Kay Seto, Man Fung Yuen
- Clin Mol Hepatol. 2022;28(4):890-911. Published online June 3, 2022
-
View: 5548 Download: 187 Web of Science: 31 Crossref: 33
- Review
- Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
- Sun Woong Kim, Jun Sik Yoon, Minjong Lee, Yuri Cho
- Clin Mol Hepatol. 2022;28(1):17-30. Published online July 20, 2021
-
View: 10276 Download: 646 Web of Science: 31 Crossref: 32
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
- Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
- Clin Mol Hepatol. 2023;29(2):206-216. Published online December 22, 2022
-
View: 6794 Download: 466 Web of Science: 35 Crossref: 32
- Editorial
- The latest global burden of liver cancer: A past and present threat
- Joo Hyun Oh, Dae Won Jun
- Clin Mol Hepatol. 2023;29(2):355-357. Published online March 9, 2023
-
View: 4264 Download: 109 Web of Science: 23 Crossref: 28
- Special Review
- Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
- Gi-Ae Kim, Joon Ho Moon, Won Kim
- Clin Mol Hepatol. 2023;29(4):831-843. Published online August 25, 2023
-
View: 4519 Download: 365 Web of Science: 23 Crossref: 28
- Original Article
- Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults
- Seogsong Jeong, Yun Hwan Oh, Seulggie Choi, Jooyoung Chang, Sung Min Kim, Joung Sik Son, Gyeongsil Lee, Joseph C Ahn, Dong Hyeon Lee, Bo Kyung Koo, Won Kim, Sang Min Park
- Clin Mol Hepatol. 2022;28(3):510-521. Published online March 17, 2022
-
View: 6792 Download: 298 Web of Science: 30 Crossref: 26
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
